Clinical Trial Update: Plan to Evaluate Early Endothelialization of a Polymer Free Sirolimus-eluting Coronary Stent System (VIVO ISARTM) Compared With Everolimus-eluting Durable Polymer Stent (XIENCE SkypointTM) in Patients Undergoing Percutaneous Coronary Intervention. [NA]

View source ↗

Summary

This clinical trial update outlines a plan to compare a polymer-free sirolimus-eluting stent (VIVO ISARTM) with an everolimus-eluting durable polymer stent (XIE…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• VIVO ISARTM (sirolimus)
• XIENCE Skypoint (everolimus)

Snippet

Sponsor: Fundación EPIC | Conditions: Coronary Artery Disease | NA | Status: ACTIVE_NOT_RECRUITING